|
|
Volumn 33 Suppl 3, Issue , 2009, Pages
|
|
Biological markers in inflammatory bowel disease: practical consideration for clinicians.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACUTE PHASE PROTEIN;
ANTIBODY;
BIOLOGICAL MARKER;
C REACTIVE PROTEIN;
CALGRANULIN;
IMMUNOGLOBULIN A;
IMMUNOLOGIC FACTOR;
LACTOFERRIN;
NEUTROPHIL CYTOPLASMIC ANTIBODY;
ALGORITHM;
ARTICLE;
BLOOD;
CHEMISTRY;
DIFFERENTIAL DIAGNOSIS;
DISEASE COURSE;
ENTERITIS;
EVIDENCE BASED MEDICINE;
FECES;
GENETICS;
HOSPITALIZATION;
HUMAN;
IMMUNOLOGY;
METABOLISM;
PRACTICE GUIDELINE;
PROGNOSIS;
SENSITIVITY AND SPECIFICITY;
ACUTE-PHASE PROTEINS;
ALGORITHMS;
ANTIBODIES;
ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC;
BIOLOGICAL MARKERS;
C-REACTIVE PROTEIN;
DIAGNOSIS, DIFFERENTIAL;
DISEASE PROGRESSION;
EVIDENCE-BASED MEDICINE;
FECES;
HUMANS;
IMMUNOGLOBULIN A;
IMMUNOLOGIC FACTORS;
INFLAMMATORY BOWEL DISEASES;
LACTOFERRIN;
LEUKOCYTE L1 ANTIGEN COMPLEX;
PRACTICE GUIDELINES AS TOPIC;
PROGNOSIS;
SENSITIVITY AND SPECIFICITY;
SEVERITY OF ILLNESS INDEX;
MLCS;
MLOWN;
|
|
EID: 79951664238
PISSN: None
EISSN: 22107401
Source Type: Journal
DOI: 10.1016/s0399-8320(09)73151-3 Document Type: Article |
|
Times cited : (93)
|
|
References (0)
|
